Edit concept Question Editor Create issue ticket

Reticulosarcoma

Reticulum Cell Sarcoma


Presentation

  • - Annualized (Present on Admission - Yes) Total Medicare Hospitalizations - Jan 2013 to Dec 2017 (Present on Admission - Yes) Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) Total Medicare Hospitalizations - Jan 2013[dexur.com]
  • Abstract We treated 101 patients with advanced (stage III and IV) lymphosarcoma and reticulosarcoma at first presentation of the disease or in relapse according to a protocol combining initial chemotherapy, complementary radiotherapy on icebergs, supplementary[ncbi.nlm.nih.gov]
  • Inclusion: Maternal care for buttocks presentation Maternal care for complete breech Maternal care for frank breech excludes: footling presentation (O32.8) incomplete breech (O32.8) O33.0 Maternal care for disproportion due to deformity of maternal pelvic[codelay.com]
  • The correlation between the histological and cytological evaluation was excellent in each case; only those tumours classified as histiocytic presented a continuous and abundant network of reticulin.[nature.com]
  • This text then presents the nomenclature and descriptions of cells of serous effusions. Other chapters consider the cytological examinations of pleural or peritoneal fluid, which often shed light on the diagnosis in leukemias and lymphomas.[books.google.com]
Withdrawn
  • Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2 6 A Study of Treatment ALK( ) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn[malacards.org]
Uremia
  • Immunosuppression from uremia could have played an important part in tumor induction in this case and might also be a significant factor in the high incidence of de-novo malignancies in renal transplant recipients.[ncbi.nlm.nih.gov]

Workup

Treatment

  • Initial DNA-interstrand cross-links (DNA-ISC) were six times higher in M5 than in M5/CDDP cells, but 24 h after treatment, both lines had completely repaired this damage. M5/CDDPc cells did not show formation of DNA-ISC at any time after treatment.[rug.nl]
  • The best results at treatment are yielded by a combination of beam and chemotherapeutic influence.[en.medicalmed.de]
  • The favourable clinical course of the tumour, and the use of complementary therapy justify a more extensive use of surgical treatment.[ncbi.nlm.nih.gov]
  • If you don't have symptoms, you may not need treatment right away. This is called watchful waiting.[icdlist.com]

Prognosis

  • The prognosis of reticulosarcoma is intermediate between that of the best-prognosis and that of the poorest-prognosis type of lymphosarcoma.[ncbi.nlm.nih.gov]
  • Differentiation from Ewing’s sarcoma is important in view of the different clinical behavior and prognosis of that lesion.[link.springer.com]
  • The prognosis varies according with the type of ALCL. During treatment, relapses may occur but these typically remain sensitive to chemotherapy. Those with ALK positive ALCL have better prognosis than ALK negative ALCL.[en.wikipedia.org]

Etiology

  • Reticulosarcoma reasons: The etiology of a disease is not studied.[en.medicalmed.de]
  • [Unusual types of encephalitis studied from clinico-etiological and histopathological aspects] Stud Cercet Inframicrobiol. 1967;18(1):55-61. Romanian. PMID: 6043540 [PubMed - indexed for MEDLINE] Vuia, O., Stanesco A.[ovidiu-vuia.de]
  • Etiology B-cell restricted markers (CD19, CD20, CD22) are expressed consistently in diffuse large cell lymphoma.[emedicine.medscape.com]

Epidemiology

  • […] chest, abdomen, or bone s (for no known reason) Skin rash or itchy skin Thrombocytopenia Weight loss (for no known reason) Diagnostic Exams Flow cytometry Immunohistochemistry Immunophenotyping Peripheral blood smear Progression and Transformation None Epidemiology[seer.cancer.gov]
  • "Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma". In Basow, DS. UpToDate. Waltham, MA: UpToDate. Akyurek, N; Uner, A; Benekli, M; Barista, I (2012).[en.wikipedia.org]
  • The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004 Aug 23. 23(38):6524-34. [Medline]. Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence.[emedicine.medscape.com]
Sex distribution
Age distribution

Prevention

  • What they ... [ Read Full Story ] May 10, 2019 If your provider is ordering nebulizers and the drugs used in them for their patients, here are things in the documentation that will help prevent a resubmission to Medicare and ease medical codi... [ Read[coder.aapc.com]
  • L-NDDP was also effective in preventing liver metastases of M5076 when administered up to 24 h prior to tumor inoculation (mean survival, 28 2 days for L-NDDP versus 22 2 days for cisplatin, P 0.05).[cancerres.aacrjournals.org]
  • John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3 43 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3 44[malacards.org]
  • Transplantation Substance Use and Addiction Surgery Surgical Innovation Surgical Pearls Teachable Moment Technology and Finance The Rational Clinical Examination Tobacco and e-Cigarettes Toxicology Trauma and Injury Treatment Adherence United States Preventive[jamanetwork.com]

Ask Question

5000 Characters left Format the text using: # Heading, **bold**, _italic_. HTML code is not allowed.
By publishing this question you agree to the TOS and Privacy policy.
• Use a precise title for your question.
• Ask a specific question and provide age, sex, symptoms, type and duration of treatment.
• Respect your own and other people's privacy, never post full names or contact information.
• Inappropriate questions will be deleted.
• In urgent cases contact a physician, visit a hospital or call an emergency service!